[ad_1]
At $7.94bn, the first quarter of 2026 fell only slightly below the $8.04bn in venture capital raised by biopharma companies in Q4 of 2025, which was the biggest quarter in years.
[ad_2]
Venture Funding Keeps A Steady Pace In Q1
Related Posts
Nothing raises over $8M in community investment round
[ad_1] London-based consumer tech brand Nothing on Thursday said it has raised over $8 million (about Rs 72 crore) in its third community investment round, […]
Funding for AI dominated in VC in 2025: Crunchbase
[ad_1] Artificial intelligence captured nearly half of all global funding to start-ups in 2025, up from 34 percent in 2024, according to newly released data […]
Investors stay the course on VC
[ad_1] For the second year in a row, a large majority of LPs in venture funds plan to invest the same amount in the asset […]